NEW YORK (GenomeWeb News) – Molecular diagnostics company Sensigen said today it plans to use a loan at 1 percent interest from the Michigan Economic Development Corporation to expand its operations in Ann Arbor.
 
The company, which is developing diagnostic tests for human papillomavirus, chronic kidney disease, lupus, and other diseases, will use the money from the loan to hire workers that have been displaced by the closing of a Pfizer facility in Michigan.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.